Simulations for experiments: Bayer-backed startup lands $20M to test out its tech
How do you get the attention of Big Pharma when you’re a small biotech startup working out of Budapest, Hungary?
For Szabolcs Nagy and his co-founders at Turbine, the golden ticket came through Bayer’s grant program for digital health, G4A, for which the company was selected a few years back.
“We roamed around the building and sort of just knocked on a whole bunch of doors after a lot of introductions,” Nagy told Endpoints News.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.